Atrial fibrillation (AF), as the most common cardiac rhythm disturbance, gains in importance not only for the persons affected, but also for health care and social economy due to thromboembolic events, of which stroke is the most serious, disabling, and life threatening one. Cardiac embolism is due to thrombus formation mainly in the left atrial appendage (LAA). The pathophysiology leading to increased thrombogenicity is complex and requires a remodelling of the LAA structure, decreased LAA blood flow, activation of inflammatory processes, deviations of the hemostatic/fibrinolytic system, and activation/dysfunction of endothelial/endocardial cells. Altogether, a prothrombotic state proposed by Virchow more than 150 years ago. The presence of a LAA thrombus, therefore, is a result of a dynamic process of clot formation and lysis. A comprehensive understanding of this pathophysiology is helpful to optimize the management of patients at high risk of cardioembolic stroke. Especially those with contraindications for oral anticoagulation are in a need of an alternative approach that is not associated with a long-term risk of hemorrhage and other attendant circumstances. The reasonable alternative may be the exclusion of the LAA cavity from circulation by either surgical or percutaneous catheter-based procedures.
B. Leithäuser et al. / A new strategy for prevention of cardioembolic stroke113]. There is a fivefold increased risk of stroke and thromboembolism with AF when compared to sinus rhythm [128]. On the assumption that more than 90% of all cardiac thrombi in patients with AF form in the LAA, and the fact that thrombi have been identified in 15-20% of patients with AF who have clinical risk factors for ischemic stroke [8,119], it has been deemed to be "our most lethal attachment" [60].The mechanism of thrombus formation in the LAA with subsequent embolization is undoubtedly complex. It requires a combination of abnormal blood stasis, endothelial or endocardial dysfunction and an activated state of the coagulation system, thus reflecting a pathophysiology proposed by Rudolf Virchow in 1856 and named as Virchow's triad for thrombogenesis [19].Although the incidence of thromboembolism in atrial fibrillation can be dramatically reduced with the use of anticoagulants, particularly warfarin [44,50], this option continues to be underused, even in eligible patients [16,43,45,49]. Obliteration or amputation of the LAA may help to reduce the risk of thromboembolism [8,86], above all in patients with an equally high risk of stroke and bleeding [28,36,58,74].